Skip to main content

and
Your search also matched 6 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Long-term neurotoxicity and quality of life in testicular cancer survivors—a nationwide cohort study

Include preview-only content
  1. Article

    Open Access

    Glomerular filtration rate measurement during platinum treatment for urothelial carcinoma: optimal methods for clinical practice

    We assessed the accuracy of four estimated glomerular filtration rate (eGFR) methods: MDRD, Cockcroft–Gault, CKD-EPI, and Wright.

    Dag Rune Stormoen, Ulla Nordström Joensen in International Journal of Clinical Oncology (2024)

  2. Article

    Open Access

    Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database

    Active surveillance after orchiectomy is the preferred management in clinical stage I (CSI) germ-cell tumours (GCT) associated with a 15 to 30% relapse rate.

    Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, Di Maria Jiang in British Journal of Cancer (2023)

  3. Article

    Open Access

    Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)

    To report on the clinical characteristics, outcome, and frequency of peritoneal carcinosis (PC) in patients with advanced germ cell tumors (GCT), a multicenter registry analysis was carried out.

    Christoph Seidel, Marcus Hentrich, Stefanie Zschäbitz in World Journal of Urology (2022)

  4. Article

    Open Access

    The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)

    The prognostic significance of lactate dehydrogenase (LDH) in patients with metastatic seminoma is not defined. We investigated the prognostic impact of LDH levels prior to first-line systemic treatment and ot...

    Christoph Seidel, Gedske Daugaard, Tim Nestler, Alexey Tryakin in World Journal of Urology (2021)

  5. Article

    Open Access

    A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)

    Elevated serum levels of luteinizing hormone and slightly decreased serum levels of testosterone (mild Leydig cell insufficiency) is a common hormonal disturbance in testicular cancer (TC) survivors. A number ...

    Mikkel Bandak, Niels Jørgensen, Anders Juul, Jakob Lauritsen in BMC Cancer (2017)

  6. Article

    Open Access

    Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin

    Cancers of unknown primary (CUPs) constitute ~5% of all cancers. The tumors have an aggressive biological and clinical behavior. The aim of the present study has been to uncover whether CUPs exhibit distinct m...

    Jonas Vikeså, Anne Kirstine H Møller, Bogumil Kaczkowski, Rehannah Borup in BMC Cancer (2015)

  7. Article

    Open Access

    Progressive Resistance Training and Cancer Testis (PROTRACT) - Efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial

    Standard treatment for patients with disseminated germ cell tumors is combination chemotherapy with bleomycin, etoposide and cisplatin (BEP). This treatment is highly effective, but the majority of patients ex...

    Jesper F Christensen, Jesper L Andersen, Lis Adamsen, Birgitte Lindegaard in BMC Cancer (2011)